Memory Awareness Influences Everyday Decision Making Capacity about Medication Management in Alzheimer's Disease

Table 1

Demographics, cognition, and metacognition.

	HE (𝑛=50)	UAD (𝑛=19)	AAD (𝑛=23)	F	df	P
Age	68.00 (7.40)	78.52 (6.51)	77.26 (9.24)	0.27	1. 40	0.608
Education	15.66 (2.30)	14.83 (2.76)	16.79 (3.24)	4.50	1. 40	0.040
% Female	58	48	47	—	1	0.610
% Caucasian	78	83	100	—	1	0.079
MMSE (0 to 30)	29.24 (1.27)	24.35 (2.84)	24.37 (3.02)	0.01	1. 40	0.982
Memory	0.94 (0.09)	0.70 (0.17)	0.68 (0.15)	0.08	1. 15	0.779
Metamemory	0.61 (0.57)	0.18 (0.72)	0.68 (0.33)	6.67	1. 33	0.015
Depression	1.60 (2.00)	2.88 (3.60)	3.00 (2.39)	0.01	1. 29	0.917

Note. HE=healthy elder; UAD = unaware group; AAD = aware group; MMSE = mini-mental state examination; Memory = recognition discriminability index; Mood = 15 item GDS. Awareness groups were determined on the basis of the clinical rating scale (AAD = fully-moderately aware; UAD = shallow—no awareness). Analyses presented for UAD versus AAD.